Fits like a glove: Ansell notes potential $10m in synergies from KBU acquisition
At its 2024 Annual General Meeting earlier today, Ansell (ASX:ANN) reported on a year marked by strategic investments and sustainability milestones.
Read MoreTag: ANN
Ansell sees sales dip
Protective wear group, Ansell (ASX:ANN) saw a dip in sales, a near 50 per cent slump in earnings and its profit dropped by nearly half and shareholders will share in some of the pain, as will more than 1300 staff members who will lose their jobs.
Read MoreMoody’s gives Ansell acquisition a thumbs up
Moody’s gave Ansell approval this week following the company’s proposed $641 million acquisition of Kimberley-Clark’s PPE business.
Read MoreAnsell’s $400m placement yields strong returns
Big investors seized a lucrative opportunity on Tuesday as Ansell, the global leader in protective solutions, executed a $400 million placement. The move, aimed at financing the acquisition of Kimberley-Clark's PPE business, resulted in significant gains for shareholders across the board.
Read MoreAnsell suspends shares ahead of $975 million acquisition of Kimberly-Clark’s PPE business
Medical products and protective wear group, Ansell (ASX:ANN) had its shares suspended on Monday ahead the announcement of its proposed acquisition of the personal protective equipment business of giant US paper products group, Kimberley-Clark.
Read MoreAnsell joins trend of narrowing earnings guidance amidst softening demand
Ansell (ASX:ANN), like other major industrial players this interim reporting season, has followed suit in 'narrowing' its earnings guidance without explicitly signaling a potential reduction in results by June 30.
Read MoreAnsell optimistic despite challenges
The decline of the Covid-19 boom has continued to adversely affect Ansell during 2022-23. However, the management is optimistic about improving conditions.
Read MoreAnsell stocks plummet amid glove glut and earnings warning
18 Jul 2023 – Renowned gloves maker Ansell (ASX:ANN) has issued another warning about an earnings slowdown, attributing it to a surplus of unsold products resulting from the COVID-19 pandemic.
Read MoreIndustrials Intel: JHX, CSL, ANN
A bit of a mixed bag from three of our big industrial companies on Tuesday, with James Hardie and Ansell both taking a recent earnings hit but old reliable CSL still going strong.
Read MoreAnsell Pushes Past Tricky Period
According to Australian investors, the headache from the hangover of the Covid boom 2020-2021 year seems to have eased for protective gear products company Ansell.
Read MoreANN – Morgans rates the stock as Hold
The target price eases to $27.53 from $28.95, and the Hold rating is maintained.
Read MoreTuesday Trade Talk: ANN, DXS
Tuesday saw personal protective group Ansell confirm weaker guidance given a couple of weeks ago, while the news from property trust Dexus mixed the good with the bad.
Read MoreAnsell Left Unprotected Against External Forces
While lower margins had been expected by the market, the sharp cut to Ansell’s earnings forecasts – made in part because of two major disruptions to suppliers – was not.
Read MoreANN – Macquarie rates the stock as Underperform
Macquarie sees price as a more relative factor in the 2H and on current dynamics, retains Sell. Target falls to $30.70 from $32.00.
Read MoreANN – Macquarie rates the stock as Underperform
Macquarie downgrades to Underperform from Neutral. Target is lowered to $32.00 from $39.00.
Read MoreSometimes You Can’t Win for Losing
Strong results and increased dividends from SEEK, Ansell and Monadelphous weren’t enough to satisfy the market, with each company’s shares falling in Tuesday’s ASX session.
Read MoreHealth in Sickness for Ansell
Like Sonic, who reported yesterday, Ansell has been one of the biggest listed beneficiaries of the pandemic, with sales, profits and returns to shareholders surging in 2020-21.
Read MoreNicolin Hands Over Ansell in Good Shape
After putting off his retirement to give the company continuity through the lockdowns and other disruptions last year, Ansell CEO Magnus Nicolin will finally step down on September 1.
Read MoreHigher Demand A Prospect For Ansell
Ansell has been a beneficiary of the pandemic, causing another upgrade to earnings guidance. Is permanently higher demand for protective gloves a prospect?
Read MoreAnsell, Mirvac Up Guidance
Upgrades keep flowing, this time from protective equipment maker Ansell and property and retail group Mirvac, both of whom indicated stronger second quarters.
Read MoreDifferent Payout Strategies for Breville, Ansell
While appliance manufacturer Breville has raised eyebrows by cutting its first-half dividend by a third, protective equipment maker Ansell has chosen to raise its interim by 50%.
Read MoreANN – Credit Suisse rates the stock as Outperform
Ansell will report its first-half results on 16 February and expects to deliver organic growth above 20%, higher than Credit Suisse’s previous forecast of 14%. Outperform retained. Target is raised to $45.50 from $45.
Read MoreANN – UBS rates the stock as Neutral
Ansell released a trading update with higher growth guidance for the full financial year. UBS analysts, in response, have increased forecasts by 4% for FY21. Target price is $39.60. Neutral rating retained.
Read MoreANN – Macquarie rates the stock as Underperform
At its 2020 Capital Markets Day, Ansell did not update on guidance but did revise medium to longer-term targets. Management believes a bulk of the virus-related surge in PPE demand will prove permanent, requiring increased capex in FY21-22 to support production capacity.
Read MoreANN – UBS rates the stock as Neutral
First quarter manufacturing (PMI) data has indicated the recovery continues. Separately, UBS notes an apparent trough in butadiene pricing and an increase in natural rubber latex pricing early in the second half buying period.
Read MoreANN – UBS rates the stock as Neutral
Ansell’s FY20 result is considered strong by UBS with robust healthcare GBU performance. The Industrial GBU was impacted by covid-19 but still ahead of the broker’s estimate.
Read MorePandemic Boost For PPE Seals Solid Result At Ansell
Personal protective equipment manufacturer Ansell will lift its dividend for the 17th year in a row thanks to the impact of COVID-19 on its expanding range of PPE products (especially gloves and protective suits).
Read MoreANN – UBS rates the stock as Neutral
UBS forecasts FY20 revenue of US$1,572, up 5% versus last year. The broker highlights the growth in the second half is driven by the healthcare division.
Read MoreANN – Credit Suisse rates the stock as Outperform
Ansell will report its results on August 25. Credit Suisse forecasts EBIT of US$212m. A final dividend of US$0.30 per share is expected.
Read MoreANN – UBS rates the stock as Neutral
UBS points out PMI data for the fourth quarter indicates manufacturing is recovering at a faster-than-expected pace.
Read MorePandemic Forces Ansell To Delay Leadership Change
The lockdowns and travel bans triggered by the COVID-19 pandemic has forced Ansell, the protective suits and glove manufacturer to defer plans to select a new CEO by six months.
Read MoreANN – Credit Suisse rates the stock as Outperform
Credit Suisse believes the increase in PPE demand, and single-use examination gloves in particular, is structural and will remain a focus post the pandemic.
Read MoreAnsell Shares Rally As Virus Spurs Demand For Protective Wear
Protective products maker Ansell has reaffirmed its 2019-20 guidance and confirmed that the coronavirus has lifted demand for its goods, but cautioned about it being a long term trend.
Read MoreNo Opportunities: Ansell Extends Buyback
Ansell has come down firmly on the side of shareholders by deciding to extend its ear old share buyback after finding no yummy takeovers.
Read MoreAnsell Profit, Dividend Edge Higher
Ansell shares were up more than 7% at one stage yesterday as investors gave what appeared to be a modest result (which included a small nudge up to the final dividend) for 2018-19 a big thumbs up.
Read MoreANN – Citi rates the stock as Buy
Citi has revised down earnings-per-share forecasts for Ansell, citing late deployment of acquisition capital and an extension of the buyback period.
Read MoreANN – Credit Suisse rates the stock as Upgrade to Outperform from Neutral
Raw material prices have eased. Raw materials account for around 60% of the company’s cost of goods sold. Credit Suisse expects Ansell will achieve only a modest benefit in the second half but forecasts a benefit of around 5% for the first half of FY20.
Read MoreANN – Credit Suisse rates the stock as Neutral
First half results were ahead of Credit Suisse estimates, although the top line disappointed as global markets weakened. This situation is expected to continue, despite the company targeting 3-4% organic sales growth in FY19.
Read MoreANN – UBS rates the stock as Neutral
Ansell has announced the acquisition of US industrial glove manufacturer, Ringers Gloves, for US$70m. UBS incorporates the acquisition into forecasts and updates for the share buyback, resulting in upgrades to earnings per share of 0.8% in FY19 and 1.6% in FY20.
Read MoreAnsell Embarks On Efficiency Drive
While Ansell is targeting savings by closing three manufacturing facilities, raw material costs remain the key risk for the earnings outlook.
Read More
